(Q46545539)

English

Effect of metformin, orlistat and pioglitazone treatment on mean insulin resistance and its biological variability in polycystic ovary syndrome.

scientific article published on 10 June 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18547343%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Effect of metformin, orlistat and pioglitazone treatment on mean insulin resistance and its biological variability in polycystic ovary syndrome (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18547343%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

polycystic ovary syndrome

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

insulin resistance

1 reference

based on heuristic

inferred from title

polycystic ovary

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18547343%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Stephen L. Atkin

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18547343%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

L W Cho

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18547343%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

E S Kilpatrick

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18547343%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

B G Keevil

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18547343%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

10 June 2008

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18547343%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Clinical Endocrinology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18547343%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

70

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18547343%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18547343%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

233-237

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18547343%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2008.03309.X

21 January 2018

Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2008.03309.X

21 January 2018

The biological variation of insulin resistance in polycystic ovarian syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2008.03309.X

21 January 2018

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2008.03309.X

21 January 2018

Orlistat is as beneficial as metformin in the treatment of polycystic ovarian syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2008.03309.X

21 January 2018

Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2008.03309.X

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2008.03309.X

21 January 2018

Generation and application of data on biological variation in clinical chemistry

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2008.03309.X

21 January 2018

Metformin therapy improves ovulatory rates, cervical scores, and pregnancy rates in clomiphene citrate-resistant women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2008.03309.X

21 January 2018

Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2008.03309.X

21 January 2018

Effects of metformin on ovulation rate, hormonal and metabolic profiles in women with clomiphene-resistant polycystic ovaries: a randomized, double-blinded placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2008.03309.X

21 January 2018

Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2008.03309.X

21 January 2018

Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2008.03309.X

21 January 2018

Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2008.03309.X

21 January 2018

Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2008.03309.X

21 January 2018

Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese, insulin-resistant women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2008.03309.X

21 January 2018

Pioglitazone and metformin in obese women with polycystic ovary syndrome not optimally responsive to metformin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2008.03309.X

21 January 2018

Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2008.03309.X

21 January 2018

Effect of the insulin sensitizer pioglitazone on insulin resistance, hyperandrogenism, and ovulatory dysfunction in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2008.03309.X

21 January 2018

Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2008.03309.X

21 January 2018

Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2008.03309.X

21 January 2018

Repeatability characteristics of simple indices of insulin resistance: implications for research applications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2008.03309.X

21 January 2018

Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2008.03309.X

21 January 2018

Identifiers

10.1111/J.1365-2265.2008.03309.X

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18547343%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18547343%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46545539&oldid=1588373599"